Clinical limitation of bone-specific alkaline phosphatase assays.
Wu
F
F
Orr-Walker
B
B
Reid
I R
IR
D000469:Alkaline Phosphatase / Q000032:analysis* / Q000378:metabolism*; D001581:Benzothiadiazines; D015519:Bone Density / Q000187:drug effects; D001842:Bone and Bones / Q000201:enzymology*; D002986:Clinical Trials as Topic; D003429:Cross Reactions; D004232:Diuretics; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007527:Isoenzymes / Q000032:analysis / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008875:Middle Aged; D009928:Organ Specificity; D015203:Reproducibility of Results; D049993:Sodium Chloride Symporter Inhibitors / Q000494:pharmacology
D001581:Benzothiadiazines; D004232:Diuretics; D007527:Isoenzymes; D049993:Sodium Chloride Symporter Inhibitors; D000469:Alkaline Phosphatase